A detailed history of Wafra Inc. transactions in Amgen Inc stock. As of the latest transaction made, Wafra Inc. holds 37,472 shares of AMGN stock, worth $11.6 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
37,472
Previous 52,842 29.09%
Holding current value
$11.6 Million
Previous $15.2 Million 30.0%
% of portfolio
0.66%
Previous 1.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $4.13 Million - $4.99 Million
-15,370 Reduced 29.09%
37,472 $10.7 Million
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $9.18 Million - $10.4 Million
-35,908 Reduced 40.46%
52,842 $15.2 Million
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $15.4 Million - $19.2 Million
70,602 Added 389.03%
88,750 $23.9 Million
Q2 2023

Jul 21, 2023

BUY
$214.27 - $253.37 $3.89 Million - $4.6 Million
18,148 New
18,148 $4.03 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wafra Inc. Portfolio

Follow Wafra Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wafra Inc. with notifications on news.